OtherVC-backedSeries A
Brisbane, United States · Founded 2023
Xaira Therapeutics
AI-discovered medicines for hard problems.
About Xaira Therapeutics
Stealth $1B+ Series A in 2024 — one of the largest biotech launches ever. Combines AI drug design with in-house wet-lab validation.
Company facts
- Category
- Other
- Funding stage
- Series A
- Total raised
- $1B+
- Founded
- 2023
- Team size
- 201-500
- HQ
- Brisbane
- Country
- United States
- Website
- xaira.com
Founders of Xaira Therapeutics
- Marc Tessier-Lavigne
Investors backing Xaira Therapeutics
- ARCH Venture Partners
- Foresite
- Sequoia
Frequently asked questions
What does Xaira Therapeutics do?
Stealth $1B+ Series A in 2024 — one of the largest biotech launches ever. Combines AI drug design with in-house wet-lab validation.
Where is Xaira Therapeutics based?
Xaira Therapeutics is based in Brisbane, United States.
When was Xaira Therapeutics founded?
Xaira Therapeutics was founded in 2023.
How much has Xaira Therapeutics raised?
Xaira Therapeutics has raised $1B+ in their Series A round.
Who founded Xaira Therapeutics?
Xaira Therapeutics was founded by Marc Tessier-Lavigne.
Who has invested in Xaira Therapeutics?
Xaira Therapeutics is backed by ARCH Venture Partners, Foresite, Sequoia.